Tech Company Financing Transactions
HAYA Therapeutics Funding Round
HAYA Therapeutics, based in Epalinges, Lausanne Vaud, raised $65 million from Earlybird Venture Capital, Sofinnova Partners and Alexandria Venture Investments.
Transaction Overview
Company Name
Announced On
5/8/2025
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the clinical development of its lead long non-coding RNA (lncRNA) targeting candidate HTX-001 in heart failure and the continued expansion of its RNA-guided regulatory genome pipeline development engine.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Route de la Corniche 5B, Batiment Alanine
Epalinges, Lausanne Vaud, 1066
Switzerland
Epalinges, Lausanne Vaud, 1066
Switzerland
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Mission: To identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility. We are passionate and dedicated to our mission. We have a unique and differentiated proprietary platform for reprogramming disease driving cell-states. Our platform is powerful and versatile, but through partnerships we believe we can do more and help thousands of patients without a current therapeutic option. Partnering with biopharma companies with a given disease or modality expertise is essential to fulfill our mission. Each disease is a unique universe, and each target may require a different approach.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samir Ounzain
Browse more venture capital transactions:
Prev: 5/8/2025: S4labour venture capital transaction
Next: 5/8/2025: Fusion Connect venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs